PTI 428-06: A phase 2 multicenter randomized double blind placebo controlled study to assess the safety tolerability pharmacokinetics and effect of PTI-428 in subjects with cystic fibrosis

Administered By

Contributors

Start/End

  • June 19, 2018 - June 30, 2020